Kraj: Izrael
Język: angielski
Źródło: Ministry of Health
NONACOG BETA PEGOL
NOVO NORDISK LTD., ISRAEL
B02BD04
POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
NONACOG BETA PEGOL 500 IU/VIAL
I.V
Required
NOVO NORDISK A/S, DENMARK
COAGULATION FACTOR IX
Treatment and prophylaxis of bleeding in pretreated patients with haemophilia B (congenital factor IX deficiency).
2023-03-15